User contributions
From 2012.igem.org
(Latest | Earliest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 12:50, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Module/Regulation and control
- 12:43, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Characterization
- 12:01, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Module/Anti tumor
- 11:41, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Presentation
- 11:41, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Interview
- 11:37, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Overview
- 11:36, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Overview
- 11:20, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Module/Anti tumor
- 10:53, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Module/Anti tumor
- 10:34, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Module/Anti tumor
- 10:34, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Module/Anti tumor
- 10:24, 26 September 2012 (diff | hist) N File:Bmp2 1.jpg (top)
- 05:16, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Future Work
- 05:16, 26 September 2012 (diff | hist) Team:HKUST-Hong Kong/Future Work
- 15:20, 25 September 2012 (diff | hist) Team:HKUST-Hong Kong/Interview
- 15:16, 25 September 2012 (diff | hist) Team:HKUST-Hong Kong/Overview
- 12:10, 25 September 2012 (diff | hist) Team:HKUST-Hong Kong/Advisors
- 11:04, 25 September 2012 (diff | hist) Team:HKUST-Hong Kong/Interview
- 10:55, 25 September 2012 (diff | hist) Team:HKUST-Hong Kong/Interview
- 10:49, 25 September 2012 (diff | hist) Team:HKUST-Hong Kong/Overview
(Latest | Earliest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)